Effects of allergic diseases and age on the composition of serum IgG glycome in children

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Pezer, Marija ^a   Stambuk, Jerko ^a   Perica, Marija ^b   Razdorov, Genadij ^c   Banic, Ivana ^b   Vuckovic, Frano ^a   Gospic, Adrijana Miletic ^b   Ugrina, Ivo ^a   Vecenaj, Ana ^b   Bakovic, Maja Pucic ^a   Lokas, Sandra Bulat ^b   Zivkovic, Jelena ^b   Plavec, Davor ^b,d   Devereux, Graham ^e   Turkalj, Mirjana ^b,d   Lauc, Gordan ^a,c  

^a GENOS GLYCOSCIENCE RESEARCH LABORATORY   (Croatia)

^b SREBRNJAK CHILDREN S HOSPITAL   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

^d JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED IGG; IMMUNOGLOBULIN G;

AGE; BLOOD; CARBOHYDRATE ANALYSIS; CASE CONTROL STUDY; CHILD; FEMALE; GLYCOBIOLOGY; GLYCOSYLATION; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; MALE; PRESCHOOL CHILD; PROTEIN PROCESSING;

AGE FACTORS; CARBOHYDRATE SEQUENCE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GLYCOMICS; GLYCOSYLATION; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN G; MALE; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84987600758     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep33198     Document Type: Article

References (57)

1. Lux, A., Aschermann, S., Biburger, M. & Nimmerjahn, F. The pro and anti-inflammatory activities of immunoglobulin G. An Rheum Dis 69 Suppl 1, i92-96 (2010).
2. Parekh, R., Roitt, I., Isenberg, D., Dwek, R. & Rademacher, T. Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J Exp Med 167, 1731-1736 (1988).
3. Yamada, E., Tsukamoto, Y., Sasaki, R., Yagyu, K. & Takahashi, N. Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum. Glycoconjugate Journal 14, 401-405 (1997).
4. Shikata, K. et al. Structural changes in the oligosaccharide moiety of human IgG with aging. Glycoconj J 15, 683-689 (1998).
5. Bakovic, M. P. et al. High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides. J Proteome Res 12, 821-831 (2013).
6. Ruhaak, L. R. et al. Decreased levels of bisecting GlcNAc glycoforms of IgG are associated with human longevity. PLoS One 5, e12566 (2010).
7. Rook, G. A. et al. Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy. J Autoimmun 4, 779-794 (1991).
8. van de Geijn, F. E. et al. Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study. Arthritis Res Ther 11, R193 (2009).
9. Kanoh, Y. et al. Changes in serum IgG oligosaccharide chains with prostate cancer progression. Anticancer Res 24, 3135-3139 (2004).
10. Saldova, R. et al. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 17, 1344-1356 (2007).
11. Moore, J. S. et al. Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals. AIDS 19, 381-389 (2005).
12. Mehta, A. S. et al. Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis. J Virol 82, 1259-1270 (2008).
13. Novokmet, M. et al. Changes in IgG and total plasma protein glycomes in acute systemic inflammation. Sci Rep 4, 4347 (2014).
14. Parekh, R. B. et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316, 452-457 (1985).
15. Vuckovic, F. et al. Association of Systemic Lupus Erythematosus With Decreased Immunosuppressive Potential of the IgG Glycome. Arthritis & rheumatology 67, 2978-2989 (2015).
16. Trbojevic Akmacic, I. et al. Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome. Inflammatory bowel diseases 21, 1237-1247 (2015).
17. Vuckovic, F. et al. IgG Glycome in Colorectal Cancer. Clin Cancer Res 22, 3078-3086 (2016).
18. Schnaar, R. L. Glycans and glycan-binding proteins in immune regulation: A concise introduction to glycobiology for the allergist. The Journal of allergy and clinical immunology 135, 609-615 (2015).
19. Krapp, S., Mimura, Y., Jefferis, R., Huber, R. & Sondermann, P. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J Mol Biol 325, 979-989 (2003).
20. Mimura, Y. et al. The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms. Mol Immunol 37, 697-706 (2000).
21. Mimura, Y. et al. Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding. J Biol Chem 276, 45539-45547 (2001).
22. Shields, R. L. et al. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem 277, 26733-26740 (2002).
23. Kao, D. et al. A Monosaccharide Residue Is Sufficient to Maintain Mouse and Human IgG Subclass Activity and Directs IgG Effector Functions to Cellular Fc Receptors. Cell reports 13, 2376-2385 (2015).
24. Nimmerjahn, F. & Ravetch, J. V. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8, 34-47 (2008).
25. Jefferis, R. Isotype and glycoform selection for antibody therapeutics. Arch Biochem Biophys 526, 159-166 (2012).
26. Schwab, I. & Nimmerjahn, F. Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nature reviews. Immunology 13, 176-189 (2013).
27. Palm, N. W., Rosenstein, R. K. & Medzhitov, R. Allergic host defences. Nature 484, 465-472 (2012).
28. World Allergy Organization White Book on Allergy. (eds Pawankar, R., Canonica, G. W., Holgate, S. T. & Lockey, R. F.) (2011).
29. Burton, O. T. & Oettgen, H. C. Beyond immediate hypersensitivity: evolving roles for IgE antibodies in immune homeostasis and allergic diseases. Immunol Rev 242, 128-143 (2011).
30. Bousquet, J. et al. Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN project. Allergy 61, 671-680 (2006).
31. Uzzaman, A. & Cho, S. H. Chapter 28: Classification of hypersensitivity reactions. Allergy Asthma Proc 33 Suppl 1, S96-99 (2012).
32. van de Veen, W. et al. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol 131, 1204-1212 (2013).
33. Malbec, O. & Daeron, M. The mast cell IgG receptors and their roles in tissue inflammation. Immunol Rev 217, 206-221 (2007).
34. Gornik, I., Maravic, G., Dumic, J., Flogel, M. & Lauc, G. Fucosylation of IgG heavy chains is increased in rheumatoid arthritis. Clin Biochem 32, 605-608 (1999).
35. Chen, X. X., Chen, Y. Q. & Ye, S. Measuring decreased serum IgG sialylation: a novel clinical biomarker of lupus. Lupus 24, 948-954 (2015).
36. Holland, M. et al. Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCAassociated systemic vasculitis. Biochim Biophys Acta 1760, 669-677 (2006).
37. Bond, A., Alavi, A., Axford, J. S., Youinou, P. & Hay, F. C. The relationship between exposed galactose and N-acetylglucosamine residues on IgG in rheumatoid arthritis (RA), juvenile chronic arthritis (JCA) and Sjogren's syndrome (SS). Clinical & Experimental Immunology 105, 99-103 (1996).
38. Dube, R. et al. Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein. Gut 31, 431-434 (1990).
39. Cremata, J. A. et al. Hypogalactosylation of serum IgG in patients with coeliac disease. Clin Exp Immunol 133, 422-429 (2003).
40. Selman, M. H. et al. IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis. J Proteome Res 10, 143-152 (2011).
41. Barrios, C. et al. Glycosylation Profile of IgG in Moderate Kidney Dysfunction. Journal of the American Society of Nephrology: JASN 27, 933-941 (2016).
42. Pucic, M. et al. Changes in plasma and IgG N-glycome during childhood and adolescence. Glycobiology 22, 975-982 (2012).
43. Huffman, J. E. et al. Comparative performance of four methods for high-throughput glycosylation analysis of immunoglobulin G in genetic and epidemiological research. Mol Cell Proteomics 13, 1598-1610 (2014).
44. Hess, C. et al. T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies. The Journal of clinical investigation 123, 3788-3796 (2013).
45. Oefner, C. M. et al. Tolerance induction with T cell-dependent protein antigens induces regulatory sialylated IgGs. J Allergy Clin Immunol 129, 1647-1655 e1613 (2012).
46. Nie, H., Li, Y. & Sun, X. L. Recent advances in sialic acid-focused glycomics. Journal of proteomics 75, 3098-3112 (2012).
47. Lucas, A. H. IgG subclass-restricted immune responses to allergens. Springer Semin Immunopathol 12, 385-400 (1990).
48. Urbanek, R. IgG subclasses and subclass distribution in allergic disorders. Monogr Allergy 23, 33-40 (1988).
49. Martindale, S. et al. Antioxidant intake in pregnancy in relation to wheeze and eczema in the first two years of life. American journal of respiratory and critical care medicine 171, 121-128 (2005).
50. Devereux, G. et al. Low maternal vitamin E intake during pregnancy is associated with asthma in 5-year-old children. American journal of respiratory and critical care medicine 174, 499-507 (2006).
51. Allan, K. M. et al. Maternal vitamin D and E intakes during pregnancy are associated with asthma in children. The European respiratory journal 45, 1027-1036 (2015).
52. Asher, M. I. et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J. 8, 483-491 (1995).
53. Johansson, S. G. & Yman, L. In vitro assays for immunoglobulin E. Methodology, indications, and interpretation. Clinical reviews in allergy 6, 93-139 (1988).
54. Dodig, S. et al. Cut-off values for total serum immunoglobulin E between non-atopic and atopic children in north-west Croatia. Clin Chem Lab Med 44, 639-647 (2006).
55. Pucic, M. et al. High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol Cell Proteomics 10, M111 010090 (2011).
56. Balbin, M., Grubb, A., de Lange, G. G. & Grubb, R. DNA sequences specific for Caucasian G3m(b) and (g) allotypes: allotyping at the genomic level. Immunogenetics 39, 187-193 (1994).
57. Selman, M. H. et al. Immunoglobulin G glycopeptide profiling by matrix-assisted laser desorption ionization Fourier transform ion cyclotron resonance mass spectrometry. Analytical Chemistry 82, 1073-1081 (2010).